Stratum Adds Oral Probiotics to Portfolio
BLIS K12 and BLIS M18 are specific strains of Streptococcus salivarius.
Stratum Nutrition (St. Louis) has formally added oral probiotic strains BLIS K12 and BLIS M18 to its product portfolio. Stratum will exclusively distribute these ingredients for BLIS Technologies Ltd. in the United States, Canada, Europe, and other regions.
BLIS K12 and BLIS M18 are specific strains of Streptococcus salivarius. BLIS K12 supports healthy bacteria in the mouth, promoting fresh breath and immune support. BLIS M18 supports healthy teeth and gums, populating the oral cavity with beneficial bacteria and providing a less hospitable environment for bacteria such as Streptococcus mutans. Additionally, it can produce unique enzymes that may protect against dental plaque and neutralize acid that can be harmful to teeth and gums.
Brightseed launches clinically validated ingredient, Bio Gut Core, to support gut barrier function
May 21st 2025The low-dose, easy-to-formulate ingredient is a proprietary blend of two bioactives – N-trans caffeoyltyramine (NCT) and N-trans feruloyltyramine (NFT) – which were discovered by the company’s Forage AI platform.
The Nutritional Outlook Podcast Episode 39: Nutritional Outlook's Ingredients to Watch in 2025
February 25th 2025In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.
